Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures

BACKGROUND: The goal of this study was to identify a clinical biomarker signature of brain amyloidosis in the Alzheimer's Disease Neuroimaging Initiative 1 (ADNI1) mild cognitive impairment (MCI) cohort. METHODS: We developed a multimodal biomarker classifier for predicting brain amyloidosis us...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neurology
Main Authors: Apostolova, Liana G., Hwang, Kristy S., Avila, David, Elashoff, David, Kohannim, Omid, Teng, Edmond, Sokolow, Sophie, Jack, Clifford R., Jagust, William J., Shaw, Leslie, Trojanowski, John Q., Weiner, Michael W., Thompson, Paul M.
Formato: Artigo
Idioma:Inglês
Publicado: Lippincott Williams & Wilkins 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4336101/
https://ncbi.nlm.nih.gov/pubmed/25609767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000001231
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares